STOCK MARKET Lilly’s experimental weight-loss drug may be a ‘multibillion-dollar opportunity’ by user April 29, 2022 by user April 29, 2022 [ad_1] Eli Lilly & Co. Inc.’s LLY, -1.46% promising new weight-loss drug is taking aim… Read more 0 FacebookTwitterPinterestEmail
STOCK MARKET How Gilead is positioning Veklury against COVID-19 antivirals like Paxlovid by user April 28, 2022 by user April 28, 2022 [ad_1] Gilead Sciences Inc. GILD, -0.29% has steadily expanded the use of Veklury while much… Read more 0 FacebookTwitterPinterestEmail